Streetbeat News

Price Targets

BSX

Over the last 3 months, 18 Wall Street analysts have provided ratings for Boston Scientific (NYSE:BSX), with an average price target of $62.22, which is above the current price of $56.295. The consensus among these analysts is positive, with 10 bullish and 7 somewhat bullish ratings. The average price target has seen a 3.49% increase over the past month.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 5:00 pm

OPEN

Opendoor Technologies (NASDAQ:OPEN) has received 5 indifferent analyst ratings in the last quarter with no bullish or bearish ratings. The average 12-month price target among these analysts is $2.85, with a high of $3.50 and a low of $2.50. This target has decreased by 10.38% from the previous average of $3.18.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 5:00 pm

ORIC

Over the past 3 months, 4 Wall Street analysts have published opinions on ORIC Pharmaceuticals (NASDAQ:ORIC), with 2 giving a bullish and 2 a somewhat bullish rating. The average 12-month price target for ORIC is $14.75, with a high of $16.00 and a low of $14.00. This target has increased by 1.72% from the previous target of $14.50. Analysts typically review stocks quarterly or after major company updates, using financial predictions and company performance to guide their ratings.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 5:00 pm

CORT

Canaccord Genuity analyst Edward Nash has reaffirmed a Buy rating on Corcept Therapeutics (NASDAQ:CORT) and increased the price target from $37 to $38.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 4:48 pm

JCI

Oppenheimer analyst Noah Kaye has reiterated an Outperform rating on Johnson Controls International (NYSE:JCI) with a maintained price target of $66.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 4:41 pm

EPIX

Oppenheimer analyst Mark Breidenbach has reiterated an Outperform rating on ESSA Pharma (NASDAQ:EPIX) and maintained a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 4:36 pm

COST

Oppenheimer analyst Rupesh Parikh has maintained an Outperform rating on Costco Wholesale (NASDAQ:COST) and increased the price target from $630 to $675.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 4:27 pm

LHX

RBC Capital analyst Ken Herbert has reiterated an Outperform rating on L3Harris Technologies (NYSE:LHX) and maintained a price target of $225.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 4:18 pm

JCI

RBC Capital analyst Deane Dray has maintained a 'Sector Perform' rating on Johnson Controls International (JCI) but has reduced the price target from $58 to $54.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 4:16 pm

CALM

Cal-Maine Foods' stock is experiencing heightened volatility after the company reported HPAI at its Kansas facility. Despite this, Stephens & Co upgraded their price target from $45 to $50.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 4:16 pm